You are here

  • Home
  • Archive
  • Volume 5, Issue 5
  • Intravenous thrombolysis guided by a telemedicine consultation system for acute ischaemic stroke patients in China: the protocol of a multicentre historically controlled study

Article Text

Article menu

Download PDFPDF

XML
Health services research
Protocol
Intravenous thrombolysis guided by a telemedicine consultation system for acute ischaemic stroke patients in China: the protocol of a multicentre historically controlled study
  1. Ziwen Yuan1,
  2. Bo Wang2,
  3. Feijiang Li3,
  4. Jing Wang1,
  5. Jin Zhi1,
  6. Erping Luo3,
  7. Zhirong Liu1,
  8. Gang Zhao1
  1. 1Department of Neurology, Xijing Hospital, The Fourth Military Medical University, Xìan, China
  2. 2Department of Epidemiology, The Fourth Military Medical University, Xìan, China
  3. 3School of Biomedical Engineering, The Fourth Military Medical University, Xìan, China
  1. Correspondence to Professor Zhirong Liu; liuzhir{at}fmmu.edu.cn and Professor Gang Zhao; zhaogang{at}fmmu.edu.cn

Abstract

Introduction The rate of intravenous thrombolysis with tissue-type plasminogen activator or urokinase for stroke patients is extremely low in China. It has been demonstrated that a telestroke service may help to increase the rate of intravenous thrombolysis and improve stroke care quality in local hospitals. The aim of this study, also called the Acute Stroke Advancing Program, is to evaluate the effectiveness and safety of decision-making concerning intravenous thrombolysis via a telemedicine consultation system for acute ischaemic stroke patients in China.

Methods and analysis This is a multicentre historically controlled study with a planned enrolment of 300 participants in each of two groups. The telestroke network consists of one hub hospital and 14 spoke hospitals in underserved regions of China. The usual stroke care quality in the spoke hospitals without guidance from the hub hospital will be used as the historical control. The telemedicine consultation system is an interactive, two-way, wireless, audiovisual system accessed on portable devices. The primary outcome is the percentage of patients treated with intravenous thrombolysis within 4.5 h of stroke onset.

Ethics and dissemination The project has been approved by the Institutional Review Board of Xijing Hospital. The results will be published in scientific journals and presented to local government and relevant institutes.

Trial registration number NCT02088346 (12 March 2014).

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

https://doi.org/10.1136/bmjopen-2014-006704

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text